Old Testimony Spurs New Claims In Amgen-Ariad Suit
A federal judge has cleared the way for Amgen Inc. to add new claims of inequitable conduct to the declaratory judgment suit against Ariad Pharmaceuticals Inc. over its arthritis treatment patent....To view the full article, register now.
Already a subscriber? Click here to view full article